Skip to content

Exagen Inc. XGN Net margin

Net margin at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
6.7%+1.1pp
Quest Diagnostics logo
Quest DiagnosticsDGX
9.1%+0.2pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-7,965.8%-10,750pp
CareDx logo
CareDxCDNA
-2%-19.9pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
6.5%+3.4pp
Revvity logo
RevvityRVTY
8.3%-2.1pp

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

Based on trailing twelve months.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s net margin?
Exagen Inc. (XGN) reported net margin of -29.5% in Q1 2026.
How has Exagen Inc.'s net margin changed year-over-year?
Exagen Inc.'s net margin decreased by 7.9% year-over-year, from -27.3% to -29.5%.
What is the long-term trend for Exagen Inc.'s net margin?
Over 5 years (2020 to 2025), Exagen Inc.'s net margin has grown at a -5.5% compound annual growth rate (CAGR), from -39.8% to -30%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.